Tag: FabiFlu
Glenmark Commences 1000 Patients Post Marketing Surveillance Study with COVID-19
KOCHI: Glenmark Pharmaceuticals, a research-led, integrated global pharmaceutical company, has announced that it has commenced.
Glenmark Receive Regulatory Approval for Oral Antiviral Favipiravir
KOCHI: In a landmark development for COVID-19 patients in India, Glenmark Pharmaceuticals, a research-led, integrated.
Glenmark Initiates Phase 3 Clinical Trials on Antiviral Favipiravir
KOCHI: Glenmark Pharmaceuticals, a research-led, integrated global pharmaceutical company has initiated Phase 3 clinical trials.